104 related articles for article (PubMed ID: 17617146)
1. Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels.
Cheung CW; Taylor PJ; Kirkpatrick CM; Vesey DA; Gobe GC; Winterford C; Nicol DL; Johnson DW
BJU Int; 2007 Aug; 100(2):438-44. PubMed ID: 17617146
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3.
Cheung CW; Vesey DA; Nicol DL; Johnson DW
BJU Int; 2007 Feb; 99(2):454-60. PubMed ID: 17313429
[TBL] [Abstract][Full Text] [Related]
3. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
[TBL] [Abstract][Full Text] [Related]
4. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
[TBL] [Abstract][Full Text] [Related]
5. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
7. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
Zi X; Zhang J; Agarwal R; Pollak M
Cancer Res; 2000 Oct; 60(20):5617-20. PubMed ID: 11059749
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
Verschoyle RD; Greaves P; Patel K; Marsden DA; Brown K; Steward WP; Gescher AJ
Eur J Cancer; 2008 Apr; 44(6):898-906. PubMed ID: 18343654
[TBL] [Abstract][Full Text] [Related]
9. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA.
Provenzano AP; Besner GE; James PF; Harding PA
Growth Factors; 2005 Mar; 23(1):19-31. PubMed ID: 16019424
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences.
Hoh C; Boocock D; Marczylo T; Singh R; Berry DP; Dennison AR; Hemingway D; Miller A; West K; Euden S; Garcea G; Farmer PB; Steward WP; Gescher AJ
Clin Cancer Res; 2006 May; 12(9):2944-50. PubMed ID: 16675592
[TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D
BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
[TBL] [Abstract][Full Text] [Related]
14. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
Flaig TW; Glodé M; Gustafson D; van Bokhoven A; Tao Y; Wilson S; Su LJ; Li Y; Harrison G; Agarwal R; Crawford ED; Lucia MS; Pollak M
Prostate; 2010 Jun; 70(8):848-55. PubMed ID: 20127732
[TBL] [Abstract][Full Text] [Related]
15. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus).
Peterson BC; Waldbieser GC
Domest Anim Endocrinol; 2009 Aug; 37(2):74-83. PubMed ID: 19446983
[TBL] [Abstract][Full Text] [Related]
16. Increased apoptosis and decreased proliferation of colorectal cancer cells using insulin-like growth factor binding protein-4 gene delivered locally by gene transfer.
Durai R; Yang SY; Sales KM; Seifalian AM; Goldspink G; Winslet MC
Colorectal Dis; 2007 Sep; 9(7):625-31. PubMed ID: 17824980
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization, tissue distribution patterns and nutritional regulation of IGFBP-1, -2, -3 and -5 in yellowtail, Seriola quinqueradiata.
Pedroso FL; Fukada H; Masumoto T
Gen Comp Endocrinol; 2009 May; 161(3):344-53. PubMed ID: 19523384
[TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
20. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma.
Chuang ST; Patton KT; Schafernak KT; Papavero V; Lin F; Baxter RC; Teh BT; Yang XJ
J Urol; 2008 Feb; 179(2):445-9. PubMed ID: 18076934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
